PillRx only · Solution, Concentrate · Oral
Cromolyn Sodium Oral Solution (Concentrate)
Cromolyn Sodium
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.314
Latest avg · Jul 22, 2026
-5%
Since Mar 18, 2026
1
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
33
Rx · 2025 Q4
21K
Units dispensed
4
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ritedose Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 3, 2023SHORTAGEDrug shortage: Cromolyn Sodium Concentrate (Ailex Pharmaceuticals)
Cromolyn Sodium Concentrate — reported in shortage by Ailex Pharmaceuticals. Therapeutic category: Pulmonary/Allergy.
- Jul 21, 2023RECALLRecall (Class II): Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not…
CGMP deviation: product released prior to supplier approval. — Recalling firm: The Ritedose Corporation — Nationwide in the US